Cutter & CO Brokerage Inc. Acquires 336 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

Cutter & CO Brokerage Inc. grew its holdings in Omega Healthcare Investors, Inc. (NYSE:OHIFree Report) by 4.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,542 shares of the real estate investment trust’s stock after acquiring an additional 336 shares during the quarter. Cutter & CO Brokerage Inc.’s holdings in Omega Healthcare Investors were worth $348,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the business. Allworth Financial LP increased its holdings in shares of Omega Healthcare Investors by 12.0% in the third quarter. Allworth Financial LP now owns 2,276 shares of the real estate investment trust’s stock worth $93,000 after acquiring an additional 244 shares in the last quarter. NCP Inc. boosted its position in shares of Omega Healthcare Investors by 10.3% during the second quarter. NCP Inc. now owns 3,310 shares of the real estate investment trust’s stock worth $113,000 after buying an additional 310 shares during the period. V Square Quantitative Management LLC boosted its position in shares of Omega Healthcare Investors by 49.5% during the third quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock worth $40,000 after buying an additional 323 shares during the period. Pasadena Private Wealth LLC raised its stake in Omega Healthcare Investors by 2.9% in the second quarter. Pasadena Private Wealth LLC now owns 12,049 shares of the real estate investment trust’s stock valued at $413,000 after buying an additional 335 shares during the period. Finally, Bay Colony Advisory Group Inc d b a Bay Colony Advisors raised its stake in Omega Healthcare Investors by 4.7% in the second quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors now owns 7,574 shares of the real estate investment trust’s stock valued at $259,000 after buying an additional 342 shares during the period. 65.25% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on OHI. BMO Capital Markets increased their target price on Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a research note on Monday, October 7th. Mizuho lowered Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and increased their target price for the stock from $34.00 to $35.00 in a research note on Thursday, July 25th. Berenberg Bank began coverage on Omega Healthcare Investors in a research note on Friday, October 18th. They set a “buy” rating and a $45.00 price objective on the stock. Scotiabank raised their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research note on Monday, August 26th. Finally, Wells Fargo & Company reaffirmed an “overweight” rating and issued a $43.00 target price (up previously from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Eight investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $37.80.

Get Our Latest Research Report on OHI

Omega Healthcare Investors Trading Down 0.1 %

Shares of NYSE:OHI traded down $0.04 during midday trading on Tuesday, reaching $41.53. The company’s stock had a trading volume of 93,486 shares, compared to its average volume of 1,635,262. The firm has a market capitalization of $10.71 billion, a price-to-earnings ratio of 31.76, a PEG ratio of 1.34 and a beta of 1.00. The company has a debt-to-equity ratio of 1.19, a quick ratio of 5.79 and a current ratio of 5.79. The firm has a 50 day moving average price of $40.17 and a two-hundred day moving average price of $35.71. Omega Healthcare Investors, Inc. has a fifty-two week low of $27.53 and a fifty-two week high of $41.95.

Omega Healthcare Investors (NYSE:OHIGet Free Report) last announced its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. The business had revenue of $252.70 million during the quarter, compared to analyst estimates of $205.92 million. During the same period in the prior year, the firm earned $0.74 earnings per share. The firm’s revenue for the quarter was up 17.5% compared to the same quarter last year. As a group, analysts forecast that Omega Healthcare Investors, Inc. will post 2.69 earnings per share for the current year.

Omega Healthcare Investors Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Monday, November 4th will be paid a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a yield of 6.45%. The ex-dividend date is Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 204.58%.

Insider Buying and Selling

In other news, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the transaction, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at $4,025,000. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the transaction, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is owned by company insiders.

About Omega Healthcare Investors

(Free Report)

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.

Featured Stories

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHIFree Report).

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.